--- title: "Hengrui Medicine surges 10% as Q3 profit jumps 89%" type: "News" locale: "en" url: "https://longbridge.com/en/news/303309840.md" description: "Hengrui Medicine (1276.HK) surges 10% in Hong Kong trading after Q3 net profit jumped 89%, beating estimates." datetime: "2026-10-28T01:35:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/303309840.md) - [en](https://longbridge.com/en/news/303309840.md) - [zh-HK](https://longbridge.com/zh-HK/news/303309840.md) generator: "portal-rs" --- # Hengrui Medicine surges 10% as Q3 profit jumps 89% Hengrui Medicine (1276.HK) surged **9.57%** in Hong Kong trading to HK$**49.000**, spiking more than 5% within five minutes at one point during the session. Third-quarter net profit soared **89%** year on year to RMB **2.458 billion**, far exceeding market expectations. Revenue climbed **20.55%** to RMB **8.95 billion**, driven by robust innovative drug sales and a **31%** increase in licensing income that included a major deal with Novo Nordisk. For the first nine months, net profit attributable to shareholders rose **20.38%** from a year earlier. ### Related Stocks - [01276.HK](https://longbridge.com/en/quote/01276.HK.md) ## Related News & Research - [Hengrui Announces Drug Inclusions in China’s 2026 NRDL](https://longbridge.com/en/news/305570916.md) - [H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker](https://longbridge.com/en/news/306367494.md) - [Why Sam’s Club is selling down jackets for just US$60 in China: ‘hook product’](https://longbridge.com/en/news/306362959.md) - [Nio Firefly debuts Haven special edition in Oslo, plans spring 2027 launch in Europe](https://longbridge.com/en/news/306380548.md) - [Dutch court bars EU sales of BYD Ti7, citing infringement of Land Rover Defender design rights](https://longbridge.com/en/news/306379119.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**